Lexaria Bioscience Corp., Proprietary Drug Delivery Technology, CEO Clip Video
b"Vancouver, British Columbia--(Newsfile Corp. - April 27, 2021) - Lexaria Bioscience Corp. (CSE: LXX) (NASDAQ: LEXX) - Chris Bunka, CEO and Chairman of Lexaria Bioscience, speaks about the Company's proprietary drug delivery technology, DehydraTECH\xe2\x84\xa2.\nIf you cannot view the video above, please visit:\nLexaria Bioscience is being featured on BNN Bloomberg on May 1st - May 2nd.\nCEO Clips is the largest library of publicly traded company CEO videos in Canada and the US.
Vancouver, British Columbia--(Newsfile Corp. - April 27, 2021) - Lexaria Bioscience Corp. (CSE: LXX) (NASDAQ: LEXX) - Chris Bunka, CEO and Chairman of Lexaria Bioscience, speaks about the Company's proprietary drug delivery technology, DehydraTECH™.
If you cannot view the video above, please visit:
https://b-tv.com/lexaria-bioscience-proprietary-drug-delivery-technology-ceo-clip-90sec/
Lexaria Bioscience is being featured on BNN Bloomberg on May 1st - May 2nd.
Lexaria Bioscience Corp. (CSE: LXX) (NASDAQ: LEXX)
www.lexariabioscience.com
About CEO Clips:
CEO Clips is the largest library of publicly traded company CEO videos in Canada and the US. These 90 second video profiles broadcast on national TV and online via 15 top financial sites including: Thomson Reuters, Bloomberg, Yahoo! Finance and Stockhouse.com.
BTV - Business Television/CEO Clips Contact: Trina Schlingmann (604) 664-7401 x 5 [email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/81943